ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives
- PMID: 35327636
- PMCID: PMC8946771
- DOI: 10.3390/biom12030443
ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives
Abstract
Cellular functions are regulated through the gene expression program by the transcription of new messenger RNAs (mRNAs), alternative RNA splicing, and protein synthesis. To this end, the post-translational modifications (PTMs) of proteins add another layer of complexity, creating a continuously fine-tuned regulatory network. ADP-ribosylation (ADPr) is an ancient reversible modification of cellular macromolecules, regulating a multitude of key functional processes as diverse as DNA damage repair (DDR), transcriptional regulation, intracellular transport, immune and stress responses, and cell survival. Additionally, due to the emerging role of ADP-ribosylation in pathological processes, ADP-ribosyltransferases (ARTs), the enzymes involved in ADPr, are attracting growing interest as new drug targets. In this review, an overview of human ARTs and their related biological functions is provided, mainly focusing on the regulation of ADP-ribosyltransferase Diphtheria toxin-like enzymes (ARTD)-dependent RNA functions. Finally, in order to unravel novel gene functional relationships, we propose the analysis of an inventory of human gene clusters, including ARTDs, which share conserved sequences at 3' untranslated regions (UTRs).
Keywords: ADP-ribosylation; ARTs; MARylation; PARylation; mRNA regulation; poly-ADP-ribosylpolymerases (PARPs).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
ARTC1-mediated VAPB ADP-ribosylation regulates calcium homeostasis.J Mol Cell Biol. 2024 Jan 5;15(7):mjad043. doi: 10.1093/jmcb/mjad043. J Mol Cell Biol. 2024. PMID: 37381178 Free PMC article.
-
A role of intracellular mono-ADP-ribosylation in cancer biology.FEBS J. 2013 Aug;280(15):3551-62. doi: 10.1111/febs.12290. Epub 2013 May 10. FEBS J. 2013. PMID: 23590234 Review.
-
Players in ADP-ribosylation: Readers and Erasers.Curr Protein Pept Sci. 2016;17(7):654-667. doi: 10.2174/1389203717666160419144846. Curr Protein Pept Sci. 2016. PMID: 27090904 Review.
-
ADP-ribosylation: An emerging direction for disease treatment.Ageing Res Rev. 2024 Feb;94:102176. doi: 10.1016/j.arr.2023.102176. Epub 2023 Dec 21. Ageing Res Rev. 2024. PMID: 38141734 Review.
-
MARTs and MARylation in the Cytosol: Biological Functions, Mechanisms of Action, and Therapeutic Potential.Cells. 2021 Feb 3;10(2):313. doi: 10.3390/cells10020313. Cells. 2021. PMID: 33546365 Free PMC article. Review.
Cited by
-
Development of Ferroptosis-Associated ceRNA Network in Periodontitis.Int Dent J. 2023 Apr;73(2):186-194. doi: 10.1016/j.identj.2022.05.004. Epub 2022 Jul 7. Int Dent J. 2023. PMID: 35810010 Free PMC article.
-
A deep learning method to predict bacterial ADP-ribosyltransferase toxins.Bioinformatics. 2024 Jul 1;40(7):btae378. doi: 10.1093/bioinformatics/btae378. Bioinformatics. 2024. PMID: 38885365 Free PMC article.
-
A ferroptosis-related ceRNA network for investigating the molecular mechanisms and the treatment of neonatal hypoxic-ischemic encephalopathy.Transl Pediatr. 2024 Jan 29;13(1):119-136. doi: 10.21037/tp-23-596. Epub 2024 Jan 22. Transl Pediatr. 2024. PMID: 38323182 Free PMC article.
-
Identification of Poly(ADP-ribose) Polymerase 9 (PARP9) as a Potent Suppressor for Mycobacterium tuberculosis Infection.Phenomics. 2023 Sep 4;4(2):158-170. doi: 10.1007/s43657-023-00112-2. eCollection 2024 Apr. Phenomics. 2023. PMID: 38884060
-
The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies.Pathogens. 2023 Feb 2;12(2):240. doi: 10.3390/pathogens12020240. Pathogens. 2023. PMID: 36839512 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous